Radon and lung cancer: A cost-effectiveness analysis

American Journal of Public Health

Volumn 89, Issue 3, 1999, Pages 351-357

  Ford, Earl S ^a,c   Kelly, Alison E ^a   Teutsch, Steven M ^b   Thacker, Stephen B ^b   Garbe, Paul L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADON;

AGE; ARTICLE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CIGARETTE SMOKING; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; ENVIRONMENTAL EXPOSURE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; PREVENTIVE HEALTH SERVICE;

EID: 0033017029     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.89.3.351     Document Type: Article

References (40)

1. Technical Support Document for the 1992 Citizen's Guide to Radon. Washington, DC: US Environmental Protection Agency; 1992. EPA publication 400-R-92-011.
2. A Citizen's Guide to Radon. Washington, DC: US Environmental Protection Agency, US Dept of Health and Human Services; 1986.
3. A Citizen's Guide to Radon. 2nd ed. Washington, DC: US Environmental Protection Agency, US Dept of Health and Human Services; 1992.
4. Nero AV Jr. Elements of a control strategy for control of indoor radon. In: Nazaroff WW, Nero AV Jr, eds. Radon and Its Decay Products in Indoor Air. New York, NY: John Wiley & Sons Inc; 1988:459-487.
5. Abelson PH. Uncertainties about health effects of radon. Science. 1990;250:353.
6. Moeller DW, Fujimoto K. Cost evaluation of control measures for indoor radon progeny. Health Phys. 1984;46:1181-1193.
7. Castren O. Strategies to reduce exposures to indoor radon. Radiat Protection Dosimetry 1988;24:487-490.
8. Bierma TJ. A Cost-Effectiveness Analysis of Policies for Reducing the Risks From Indoor Radon [dissertation]. Chicago, Ill: University of Illinois at Chicago; 1989.
9. Puskin JS, Nelson CB. EPA's perspective on risks from residential radon exposure. J Air Pollut Control Assoc. 1989;39:915-920.
10. Nazaroff WW, Teichman K. Indoor radon. Environ Sci Technol. 1990;24:775-782.
11. Indoor Radon and Decay Products: Concentrations, Causes, and Control Strategies. Washington, DC: US Dept of Energy; 1990. DOE publication ER-0480P.
12. Mossman KL, Sollito MA. Regulatory control of indoor Rn. Health Phys. 1991;60:169-176.
13. Wozniak S. Lung cancer and radon [letter]. Lancet. 1992;304:1571.
14. Letourneau EG, Krewski D, Zielinski JM, McGregor RG. Cost effectiveness of radon mitigation in Canada. Radiat Protection Dosimetry. 1992;45(suppl 1-4):593-598.
15. Petitti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. New York, NY: Oxford University Press Inc; 1994.
16. Public Health Agencies 1991: An Inventory of Programs and Block Grant Expenditures. Washington, DC: Public Health Foundation; 1991.
17. Doyle JK, McClelland GH, Schulze WD, Elliott SR, Russell GW. Protective responses to household risk: a case study of radon mitigation. Risk Analysis. 1991;11:121-134.
18. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q. 1992;70: 81-125.
19. Rice DP, Hodgson TA, Sinsheimer P, Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. Milbank Q. 1986;64:489-547.
20. Doyle JK, McClelland GH, Schulze WD, et al. An Evaluation of Strategies for Promoting Effective Radon Mitigation. Washington, DC: US Environmental Protection Agency; 1990. EPA publication 230-02-90-075.
21. Ford ES, Eheman CR. Radon retesting and mitigation behavior among the U.S. population. Health Phys. 1997;72:611-614.
22. Conference of Radiation Control Program Directors. CRCPD'S Radon Risk Communication Study results. Radon Bull. 1993;3(3):1.
23. National Research Council. Health Risks of Radon and Other Internally Deposited Alpha-Emitters. BEIR IV. Washington, DC: National Academy Press; 1988.
24. National Residential Radon Survey. Washington, DC: US Environmental Protection Agency; 1992. EPA publication 402-R-92-011.
25. EPAs Map of Radon Zones. Washington, DC: US Environmental Protection Agency; 1993. EPA publication 402-R-93-071.
26. Axelson O. Aspects on confounding in occupational health epidemiology. Scand J Work Environ Health. 1978;4:85-89.
27. Maillie HD, Simon W, Greenspan BS, Watts RJ, Quinn BR. The influence of life table corrections for smokers and nonsmokers on the health effects of radon using the BEIR IV method. Health Phys. 1994;66:615-620.
28. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. Rockville, Md: US Dept of Health and Human Services; 1989. DHHS publication CDC 89-8411.
29. The Health Benefits of Smoking Cessation. A Report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services; 1990. DHHS publication CDC 90-8416.
30. Centers for Disease Control and Prevention. Health promotion and disease prevention, United States, 1990. Vital Health Stat 10. 1993; No. 185.
31. Lubin JH, Steindorf K. Cigarette use and the estimation of lung cancer attributable to radon in the United States. Radiat Res. 1995;141: 79-85.
32. Evdokimoff V, Ozonoff D. Compliance with EPA guidelines for follow-up testing and mitigation after radon screening measurements. Health Phys. 1992;63:215-217.
33. Samet JM, Hornung RW. Review of radon and lung cancer risk. Risk Analysis. 1990;10:65-75.
34. Bowie C, Bowie SHU. Radon and health. Lancet. 1991;337:409-413.
35. Price PN, Nero AV. Joint analysis of long- and short-term radon monitoring data from the northern U.S. Environ Int. 1996;22(suppl 1): S699-S714.
36. Warner KE, Mendez D, Courant PN. Toward a more realistic appraisal of the lung cancer risk from radon: the effects of residential mobility. Am J Public Health. 1996;86:1222-1227.
37. Oster G, Huse DM, Delea TE, Colditz GA. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA. 1986;256:1315-1318.
38. Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counseling smokers to quit. JAMA. 1989;261:75-79.
39. Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA. 1996;275:1247-1251.
40. Ford ES, Eheman CE, Siegel PZ, Garbe PL. Radon awareness and testing behavior: findings from the Behavioral Risk Factor Surveillance System, 1989-1992. Health Phys. 1996;70:363-366.